Step 3: Review and decision by the Patient and Scientific Board

Granting access to data from clinical trials sponsored by LEO Pharma shall be made for scientific purposes. The review process of the Patient and Scientific Review Board is necessary to determine that the research proposal has a valid scientific rationale, is non-commercial, and is in the best interest of patients.

The Patient and Scientific Review Board will make one of three decisions:

1. Approval to provide access

2. Rejection of the research proposal

3. Re-submission possible.

The Patient and Scientific Review Board makes its decisions independently from LEO Pharma.

Currently, four Board meetings are scheduled per year.